Palabras clave
Epidemiology
Hematologic Neoplasms
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar la tendencia de la incidencia y mortalidad de leucemias y linfomas infantiles, así como estimar la supervivencia utilizando la razón mortalidad/incidencia en Mato Grosso. Métodos: Se analizaron los datos del registro de cáncer de base poblacional de Mato Grosso de 2001 a 2017, así como los datos de mortalidad de 2001 a 2021 extraídos del Sistema de Información de Mortalidad. El análisis consistió en frecuencias, tasas de incidencia ajustadas (AIR) por millón y resultados de regresión joinpoint. Las estimaciones de supervivencia se calcularon utilizando la relación entre el número de muertes y casos incidentes [1-(M:I)] de 2013 a 2017. Resultados: Las leucemias representaron el 67,7% de los casos con una tasa de incidencia de 29,9 y 13,9 para los linfomas, mientras que la tasa de mortalidad fue de 18,0. Hubo una tendencia significativa a la baja en la incidencia de leucemias en ambos sexos -4,0% y en mujeres -5,5%, mientras que la incidencia de linfomas y la mortalidad se mantuvieron estables. Las estimaciones de supervivencia fueron del 88% y el 74% para las leucemias y los linfomas. Conclusión: Las tasas de incidencia y mortalidad y las estimaciones de supervivencia fueron intermedias para los contextos epidemiológicos de los países de ingresos altos y medios, con una reducción significativa de la incidencia de leucemias.
Referencias
ALLEMANI C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet, 2018; 391 (10125): 1023-1075.
ASADZADEH VOSTAKOLAEI F, et al. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. The European Journal of Public Health, 2011; 21 (5): 573-577.
BERTUCCIO P, et al. Childhood cancer mortality trends in Europe, 1990-2017, with focus on geographic differences. Cancer epidemiology, 2020; (67): 101768.
BHAKTA N, et al. Childhood cancer burden: a review of global estimates. The lancet oncology, 2019; 20 (1): e 42-e53.
BRASIL. Instituto Nacional do Câncer José Alencar Gomes da Silva INCA. Estimativa 2023: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022.
BRASIL. Ministério da Saúde. Sistema de Informações em saúde - DATASUS. 2021. Disponível em: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/. Acesso em: 03 ago. 2021.
CAMARGO B, et al. Cancer incidence among children and adolescents in Brazil: First report of 14 population‐based cancer registries. International journal of cancer, 2010; 126 (3): 715-720.
CHATENOUD L, et al. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer, 2010; 116 (21): 5063-5074.
CLEGG LX, et al. Estimating average annual per cent change in trend analysis. Statistics in medicine, 2009; 28 (29): 3670-3682.
COOK MB, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiology Biomarkers & Prevention, 2009; 18 (4): 1174-1182.
CURADO MP, et al. Leukemia mortality trends among children, adolescents, and young adults in Latin America. Revista Panamericana de Salud Pública, 2011; 29 (2): 96-102.
DOLL R, et al. (Ed.). Cancer Incidence in Five Continents: Volume II–1970. Springer Science & Business Media; 2012.
FELICIANO SVM, et al. Incidence and mortality of myeloid malignancies in children, adolescents and Young adults in Brazil: A population-based study. Cancer Epidemiology, 2019; (62): 101583.
FERMAN S, et al. Childhood cancer mortality trends in Brazil, 1979–2008. Clinics, 2013; 68 (2): 219-224.
FERREIRA JMO, et al. Lymphoma subtype incidence rates in children and adolescents: first report from Brazil. Cancer epidemiology, 2012; 36 (4): e221-e226.
FIDLER MM, et al. Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ, 2016; 354.
FORCE LM, et al. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. The Lancet Oncology, 2019; 20 (9): 1211-1225.
GOUJON S, et al. Spatial and temporal variations of childhood cancers: literature review and contribution of the French national registry. Cancer medicine. 2018; 7(10): 5299-5314.
GUPTA S, et al. Treating childhood cancer in low-and middle-income countries. Cancer. Washington DC: The World Bank Group, 2015; 121-46.
HOWARD SC, et al. The My Child Matters programme: effect of public–private partnerships on paediatric cancer care in low-income and middle-income countries. The Lancet Oncology, 2018; 19 (5): e252-e266.
JOHNSTON WT, et al. Childhood cancer: Estimating regional and global incidence. Cancer epidemiology, 2021; (71): 101662.
KAATSCH P. Epidemiology of childhood cancer. Cancer treatment reviews, 2010; 36 (4): 277-285.
KARIM-KOS HE, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994 2011. Cancer epidemiology, 2016; 42: 72-81.
KIM HJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine, 2000; 19 (3): 335-351.
MARCOS-GRAGERA R, et al. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clinical and Translational Oncology, 2018; (20): 1289-1301.
PARKIN DM e BRAY F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European journal of cancer, 2009; 45 (5): 756-764.
REULEN RC, et al. Long-term cause-specific mortality among survivors of childhood cancer. Jama, 2010; 304 (2): 172-179.
SIEGEL DA, et al. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. JNCI: Journal of the National Cancer Institute, 2023; 115 (11): 1337-1354.
SILVA NP, et al. Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Revista Panamericana de Salud Pública, 2024; 48: e11.
STELIAROVA‐FOUCHER E, et al. International classification of childhood cancer. Cancer, 2005; 103 (7): 1457-1467.
STELIAROVA-FOUCHER E, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. The Lancet Oncology, 2017; 18 (6): 719-731.
STELIAROVA-FOUCHER E, et al. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study. The Lancet Oncology, 2018; 19 (9): 1159-1169.
SUNKARA V e HÉBERT JR. The application of the mortality‐to‐incidence ratio for the evaluation of cancer care disparities globally. Cancer, 2016; 22 (3): 487-488.
TRALLERO J, et al. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018. Frontiers in Oncology, 2023; (13): 1197850.
WARD ZJ, et al. Estimating the total incidence of global childhood cancer: a simulation-based analysis. The Lancet Oncology, 2019; 20 (4): 483-493.
WHO global initiative for childhood cancer: an overview. In: World Health Organization; Disponível em: https://www.who.int/docs/default-source/documents/health-topics/cancer/who-childhood-cancer-overview-booklet.pdf?sfvrsn=83cf4552_1&download=true
YEH JM, et al. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Annals of internal medicine, 2010; 152 (7): 409-417.
YOULDEN DR, et al. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Medical Journal of Australia, 2020; 212 (3): 113-120.